<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to analyse, by immunomorphometry, megakaryocytopoiesis in patients with myelodysplatsic syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>The results revealed that, in spite of marked megakaryocyte <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> suffer from severe peripheral <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Megakaryocytes in myelodisplastic syndrome have, in average, small cellular and nuclear diameter and 35.3% of them (s. c </plain></SENT>
<SENT sid="3" pm="."><plain>micromegakaryocyres) can be identified only by using immunohistochemical technique </plain></SENT>
<SENT sid="4" pm="."><plain>In conclusion, there is severe maturation disturbancy, ineffectiveness and disregulation of megakaryocytopoiesis in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>